GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (OTCPK:INRLF) » Definitions » Price-to-Funds-From-Operations

Valneva SE (Valneva SE) Price-to-Funds-From-Operations : (As of May. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Valneva SE Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Valneva SE (Valneva SE) Business Description

Industry
Traded in Other Exchanges
Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, & third-party products; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The majority is from the Commercialized vaccines segment & geographically from the United States.